LIVN Q1 2020 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q1 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$242M-3.4% YoY

Gross Profit

$171M70.3% margin

Operating Income

$23M9.5% margin

Net Income

$38M15.5% margin

EPS (Diluted)

$0.77

QoQ Revenue Growth

-15.7%

Cash Flow

Operating Cash Flow

-$106M

Free Cash Flow

-$115M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$2.5B

Total Liabilities

$1.1B

Stockholders' Equity

$1.4B

Cash & Equivalents

$126M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$242M	$251M	-3.4%
Gross Profit	$171M	$164M	+4.2%
Operating Income	$23M	-$21M	+210.9%
Net Income	$38M	-$15M	+353.1%

Revenue Segments

Neuromodulation Segment

$90M78%

Cardiovascular Segment

$25M22%

Geographic Segments

UNITED STATES

$124M51%

Locations Excluding The United States And Europe

$64M26%

Europe

$55M23%